These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38626900)

  • 1. Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
    Galliazzo S; Bucciarelli P; Barcellona D; Ciampa A; Grandone E; Malcangi G; Rescigno G; Squizzato A; Toschi V; Testa S; Poli D
    Thromb Haemost; 2024 Aug; 124(8):803-809. PubMed ID: 38626900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
    Squizzato A; Poli D; Barcellona D; Ciampa A; Grandone E; Manotti C; Moia M; Toschi V; Tosetto A; Testa S;
    Thromb Haemost; 2022 Mar; 122(3):329-335. PubMed ID: 34875702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of special conditions in patients on vitamin K antagonists.
    Marongiu F; Finazzi G; Pengo V; Poli D; Testa S; Tripodi A
    Intern Emerg Med; 2012 Oct; 7(5):407-13. PubMed ID: 21617968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
    Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
    Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
    Baumann Kreuziger LM; Kim B; Wieselthaler GM
    J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.
    Palareti G; Antonucci E; Migliaccio L; Erba N; Marongiu F; Pengo V; Poli D; Testa S; Tosetto A; Tripodi A; Moia M;
    Intern Emerg Med; 2017 Dec; 12(8):1109-1119. PubMed ID: 28501909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant Therapy in Pregnant Women with Mechanical Heart Valves: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
    Campello E; Bucciarelli P; Catalani F; Erba N; Squizzato A; Poli D;
    Thromb Haemost; 2024 Aug; 124(8):695-708. PubMed ID: 38744424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.
    Lee A; Crowther M
    J Thromb Thrombolysis; 2011 Apr; 31(3):249-58. PubMed ID: 21274594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal INR level for warfarin therapy after mechanical mitral valve replacement.
    Kamthornthanakarn I; Krittayaphong R
    BMC Cardiovasc Disord; 2019 Apr; 19(1):97. PubMed ID: 31023235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.
    Poli D; Antonucci E; Pengo V; Migliaccio L; Testa S; Lodigiani C; Coffetti N; Facchinetti R; Serricchio G; Falco P; Mangione C; Masottini S; Ruocco L; De Caterina R; Palareti G;
    Int J Cardiol; 2018 Sep; 267():68-73. PubMed ID: 29957264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing vitamin K antagonists: making the old new again.
    Eichinger S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):605-611. PubMed ID: 27913535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fifty years of clinical use of warfarin].
    Quintero-González JA
    Invest Clin; 2010 Jun; 51(2):269-87. PubMed ID: 20928982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.